Identification of three novel pathogenic mutations in cystathionine beta-synthase gene of Pakistani intellectually

Muhammad Wasim1,2, Haq N Khan1,2,3, Hina Ayesha4

  • 1Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.

Insights

Classical homocystinuria (HCU), a metabolic disorder causing intellectual disability, was screened in 429 Pakistani patients. Seven families with HCU were identified, and personalized treatment led to significant symptom improvement.

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Classical homocystinuria (HCU) is an autosomal recessive metabolic disorder caused by cystathionine-β-synthase (CBS) deficiency.
  • Symptoms include intellectual disability, ectopia lentis, and elevated plasma methionine and homocysteine.

Purpose of the Study:

  • To screen for classical homocystinuria (HCU) in intellectually disabled patients in Punjab, Pakistan.
  • To identify causative mutations in the cystathionine-β-synthase (CBS) gene.

Main Methods:

  • Biochemical and genetic analyses were performed on 429 patients with intellectual disability.
  • Targeted exonic analysis of the CBS gene was conducted.

Main Results:

  • Nine patients from seven families were diagnosed with HCU, exhibiting elevated plasma methionine and homocysteine.
  • Seven causative homozygous mutations in the CBS gene were identified, including three novel missense mutations.
  • Treatment with pyridoxine, folic acid, cobalamin, betaine, and dietary protein restriction resulted in behavioral and physical improvements.

Conclusions:

  • Early diagnosis and personalized treatment, including cofactor therapy and dietary management, can significantly improve health outcomes for HCU patients.
  • This pioneering screening initiative in Pakistan aims to reduce the burden of treatable inborn errors of metabolism in intellectually disabled individuals.
Abstract